公开(公告)号：AT519746T

公开(公告)日：2011-08-15

申请号：AT08832330

申请日：2008-09-17

Applicant: ABBOTT LAB

Inventor： FLENTGE CHARLES ,  HUTCHINSON DOUGLAS ,  BETEBENNER DAVID ,  DEGOEY DAVID ,  DONNER PAMELA ,  KATI WARREN ,  KRUEGER ALLAN ,  LIU DACHUN ,  LIU YAYA ,  LONGENECKER KENTON ,  MARING CLARENCE ,  MOTTER CHRISTOPHER ,  PRATT JOHN ,  RANDOLPH JOHN ,  ROCKWAY TODD ,  STEWART KENT ,  WAGNER ROLF ,  BARNES DAVID ,  CHEN SHUANG ,  FRANCZYK THADDEUS ,  GAO YI ,  HAIGHT ANTHONY ,  HENGEVELD JOHN ,  KOTECKI BRIAN ,  LOU XIAOCHUN ,  ZHANG GEOFF

IPC: C07D239/22 ,  C07D239/54 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10 ,  C07D417/10

公开(公告)号：AT512954T

公开(公告)日：2011-07-15

申请号：AT08831558

申请日：2008-09-17

Applicant: ABBOTT LAB

Inventor： DONNER PAMELA L ,  RANDOLPH JOHN T ,  KRUEGER ALLAN C ,  BETEBENNER DAVID A ,  HUTCHINSON DOUGLAS K ,  LIU DACHUN ,  LIU YAYA ,  LONGENECKER KENTON L ,  MARING CLARENCE J ,  PRATT JOHN K ,  ROCKWAY TODD W ,  STEWART KENT D ,  WAGNER ROLF ,  BARNES DAVID M ,  CHEN SHUANG ,  FRANCZYK II THADDEUS S ,  GAO YI ,  HAIGHT ANTHONY R ,  HENGEVELD JOHN E ,  HENRY RODGER F ,  KOTECKI BRIAN J ,  LOU XIAOCHUN ,  ZHANG GEOFF G Z

IPC: C07D239/22 ,  C07D239/54 ,  C07D239/553 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10

公开(公告)号：CA2758740A1

公开(公告)日：2010-11-04

申请号：CA2758740

申请日：2010-04-30

Applicant: ABBOTT LAB

Inventor： BORCHARDT THOMAS ,  BRACKEMYER PAUL ,  CATRON NATHANIEL ,  HENRY RODGER ,  LOU XIAOCHUN ,  RAVN MATTHEW ,  ZHANG GEOFF ,  ZHOU DELIANG

IPC: C07D295/155 ,  A61K31/496 ,  A61P35/00

Abstract: ABT-263 bis-HCl and crystalline polymorphs thereof are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.

公开(公告)号：DOP2010000084A

公开(公告)日：2010-06-15

申请号：DO2010000084

申请日：2010-03-16

Applicant: ABBOTT LAB

Inventor： STEWART KENT D ,  ZHANG GEOFF G Z ,  CHEN SHUANG ,  HENRY RODGER F ,  WAGNER ROLF ,  TUFANO MICHAEL D ,  ROCKWAY TODD W ,  RANDOLPH JOHN T ,  PRATT JOHN K ,  MOTTER CHRISTOPHER E ,  MARING CLARENCE J ,  LONGENECKER KENTON L ,  LIU YAYA ,  LIU DACHUN ,  KRUEGER ALLAN C ,  KATI WARREN M ,  HUTCHINSON DOUGLAS K ,  HUANG PEGGY P ,  FLENTGE CHARLES A ,  DONNER PAMELA L ,  DEGOEY DAVID A ,  BETEBENNER DAVID A ,  BARNES DAVID M ,  II TRADDEUS S FRANCZYK ,  GAO YI ,  HAIGHT ANTHONY R ,  HENGEVELD JOHN E ,  KOTECKI BRIAN J ,  LOU XIAOCHUN ,  SARRIS KATHY

IPC: C07D239/22 ,  C07D239/54 ,  C07D401/10 ,  C07D403/10 ,  C07D409/10 ,  C07D413/10 ,  C07D417/10

Abstract: Esta invención se relaciona con: (a) compuestos y sales de los mismos que, entre otros, inhiben el HCV; (b) intermediarios de utilidad para la preparación de dichos compuestos y sales; (c) composiciones que comprenden dichos compuestos y sales; (d) metodos para preparar dichos intermediarios, compuestos, sales y composiciones; (e) metodos de use de dichos compuestos, sales y composiciones; y (f) conjuntos de elementos que comprenden dichos compuestos, sales y composiciones.

公开(公告)号：AU2008302448A1

公开(公告)日：2009-03-26

申请号：AU2008302448

申请日：2008-09-17

Applicant: ABBOTT LAB

Inventor： HAIGHT ANTHONY R ,  RANDOLPH JOHN T ,  LONGENECKER KENTON L ,  FRANCZYK THADDEUS S II ,  BETEBENNER DAVID A ,  DEGOEY DAVID A ,  STEWART KENT D ,  TUFANO MICHAEL D ,  LIU YAYA ,  WAGNER ROLF ,  SARRIS KATHY ,  LIU DACHUN ,  BARNES DAVID M ,  ROCKWAY TODD W ,  FLENTGE CHARLES A ,  KATI WARREN M ,  KOTECKI BRIAN J ,  ZHANG GEOFF G Z ,  CHEN SHUANG ,  GAO YI ,  HENRY RODGER F ,  HUANG PEGGY P ,  PRATT JOHN K ,  DONNER PAMELA L ,  MARING CLARENCE J ,  HUTCHINSON DOUGLAS K ,  KRUEGER ALLAN C ,  LOU XIAOCHUN ,  MOTTER CHRISTOPHER E ,  HENGEVELD JOHN E

IPC: C07D239/22 ,  A61K31/513 ,  A61P31/12 ,  C07D239/54 ,  C07D401/10 ,  C07D403/10 ,  C07D409/10 ,  C07D413/10 ,  C07D417/10

Abstract: This invention relates to: (a) compounds and salts thereof that, inter alia , inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; and (e) use of such compounds, salts, and compositions.

公开(公告)号：AU2007220889A1

公开(公告)日：2007-09-07

申请号：AU2007220889

申请日：2007-02-16

Applicant: ABBOTT LAB

Inventor： FICKES MICHAEL G ,  SUN MINGHUA ,  ZHAO CHEN ,  SHEIKH AHMAD Y ,  HENRY RODGER F ,  BARNES DAVID M ,  GREGG ROBERT J ,  HAIGHT ANTHONY R ,  KOLACZKOWSKI LAWRENCE ,  WITTENBERGER STEVEN J ,  ZHANG GEOFF G Z ,  COWART MARLON D ,  LOU XIAOCHUN ,  ZHENG GUO ZHU ,  BLACK LAWRENCE A ,  CHANG SOU-JEN

IPC: C07D487/04 ,  A61K31/407

Abstract: Octahydro-pyrrolo[3,4-b]pyrrole derivatives are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Octahydro-pyrrolo[3,4-b]pyrrole compounds, methods for using such compounds, compositions for making them, and processes for preparing such compounds are disclosed herein.

公开(公告)号：BRPI1014369A2

公开(公告)日：2016-04-05

申请号：BRPI1014369

申请日：2010-04-30

Applicant: ABBOTT LAB

Inventor： ZHOU DELIANG ,  ZHANG GEOFF ,  RAVN MATTHEW ,  CATRON NATHANIEL ,  BRACKEMYER PAUL ,  HENRY RODGER ,  BORCHARDT THOMAS ,  LOU XIAOCHUN

IPC: C07D295/155 ,  A61K31/496 ,  A61P35/00

公开(公告)号：ZA201204223B

公开(公告)日：2015-12-23

申请号：ZA201204223

申请日：2012-06-08

Applicant: ABBOTT LAB

Inventor： LOU XIAOCHUN ,  ZHANG GEOFF G Z ,  KOTECKI BRIAN J ,  HENGEVELD JOHN E ,  GAO YI ,  CHEN SHUANG ,  BETEBENNER DAVID A ,  DONNER PAMELA L ,  HUANG PEGGY P ,  KATI WARREN M ,  LIU YAYA ,  MARING CLARENCE J ,  PRATT JOHN K ,  ROCKWAY TODD W ,  TUFANO MICHAEL D ,  LIU DACHUN ,  SARRIS KATHY ,  HENRY RODGER F ,  HAIGHT ANTHONY R ,  FRANCZYK II THADDEUS S ,  BARNES DAVID M ,  DEGOEY DAVID A ,  HUTCHINSON DOUGLAS K ,  KRUEGER ALLAN C ,  LONGENECKER KENTON L ,  RANDOLPH JOHN T ,  STEWART KENT D ,  WEGNER ROLF

Abstract: This invention relates to: (a) compounds and salts thereof that, inter alia , inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; and (e) use of such compounds, salts, and compositions.

公开(公告)号：IN5113DEN2012A

公开(公告)日：2015-10-23

申请号：IN5113DEN2012

申请日：2012-06-08

Applicant: ABBOTT LAB

Inventor： WAGNER ROLF ,  TUFANO MICHAEL D ,  STEWART KENT D ,  ROCKWAY TODD W ,  RANDOLPH JOHN T ,  PRATT JOHN K ,  MOTTER CHRISTOPHER E ,  MARING CLARENCE J ,  LONGENECKER KENTON L ,  LIU YAYA ,  LIU DACHUN ,  KRUEGER ALLAN C ,  KATI WARREN M ,  HUTCHINSON DOUGLAS K ,  HUANG PEGGY P ,  FLENTGE CHARLES A ,  DONNER PAMELA L ,  DEGOEY DAVID A ,  BETEBENNER DAVID A ,  BARNES DAVID M ,  CHEN SHUANG ,  FRANCZYK II THADDEUS S ,  GAO YI ,  HAIGHT ANTHONY R ,  HENGEVELD JOHN E ,  HENRY RODGER F ,  KOTECKI BRIAN J ,  LOU XIAOCHUN ,  SARRIS KATHY ,  ZHANG GEOFF G Z

IPC: C07D239/22

Abstract: Present application relates to the compounds of formula I useful to treat hepatitis C (HCV) infections. In the structure of the disclosed compounds is the uracil or thymine derivative linked via a phenylene into either fused 2- ring cyclic system (R6) or alternatively via additional two-atom linker (L) to a 5-6 membered monocycle (R6). Application further discloses polymorphs I and pseudopolymorphs of two specific compounds: N-(6(3-t-butyl-5-(2>4- dioxo-3,4-dihydropyrimidin-1 (2H)- y!)2-methoxy-pheny1)naphthalen-2- yl)methanesulfonamide and (E)-N-(4(3-t- butyl-5-(2,4-dioxo-3)4-dihydropyrimidin-1 (2H)-yl)2-method-styryl-phemyl)methanesulfonamide.

公开(公告)号：PH12013500365A1

公开(公告)日：2014-09-08

申请号：PH12013500365

申请日：2013-02-25

Applicant: ABBOTT LAB

Inventor： WAGNER ROLF ,  TUFANO MICHAEL D ,  STEWART KENT D ,  ROCKWAY TODD W ,  RANDOLPH JOHN T ,  PRATT JOHN K ,  MOTTER CHRISTOPHER E ,  MARING CLARENCE J ,  LONGENECKER KENTON L ,  LIU YAYA ,  LIU DACHUN ,  KRUEGER ALLAN C ,  KATI WARREN M ,  HUTCHINSON DOUGLAS K ,  HUANG PEGGY P ,  FLENTGE CHARLES A ,  DONNER PAMELA L ,  DEGOEY DAVID A ,  BETEBENNER DAVID A ,  BARNES DAVID M ,  CHEN SHUANG ,  FRANCZYK THADDEUS S II ,  GAO YI ,  HAIGHT ANTHONY R ,  HENGEVELD JOHN E ,  HENRY RODGER F ,  KOTECKI BRIAN J ,  LOU XIAOCHUN ,  SARRIS KATHY ,  ZHANG GEOFF G Z

IPC: C07D403/10 ,  A61K31/513 ,  A61K31/5377 ,  A61P1/16 ,  A61P31/14 ,  C07D239/22 ,  C07D239/54 ,  C07D401/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10 ,  C07D417/10 ,  C07D417/14

Abstract: This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.